-
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts
ソース: Buzz FX / 01 11 2024 02:08:16 America/Chicago
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Shares of Immunome, Inc. ( NASDAQ:IMNM - Get Free Report ) have received an average recommendati
Read more...